We are a technology-based startup  developing medical devices for coronary arteries

Delawave's solution is a
coronary imaging catheter and system for CAD treatment

Approved by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan in March 2021

  • Intravascular Optical Coherence Tomography (OCT) catheter
  • OCT diagnostic imaging system
October, 2017
  Established in Kawaguchi-shi, Saitama
April, 2018   Relocation of office to Musashino-shi, Tokyo
May, 2019
  Obtainment of first-class marketing license for medical devices (Registration No. 13B1X10297)
May, 2019   Registration of Manufacturing Business (Registration No. 13BZ201298)
March, 2021   PMDA Approval
New!! June, 2021   Reimbursement
March, 2021   PMDA Approval
Company Name Delawave, Inc.
Location 2-2-18-302 Sakai, Musashino-shi
Tokyo 180-0022 Japan
Founded October, 2017
Capital 10 Million JPY
Representative Director Kenji Taira
Sean Zhang
Capital 10 Million JPY